Sumatriptan Succinate Tablets — Class II drug recall D-0660-2020
Terminated recall by Sun Pharmaceutical Industries, Inc., reported 2020-01-22, distributed nationwide. Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
| Recall number | D-0660-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sun Pharmaceutical Industries, Inc., Cranbury, NJ, United States |
| Recall initiated | 2019-12-26 |
| Classified | 2020-01-13 |
| Reported by FDA | 2020-01-22 |
| Terminated | 2020-10-22 |
| Distributed | Nationwide (US) |
| Quantity | 207,585 blisters |
| Reason classes | specification failure |
| NDC | 62756-0522-69 |
| Expiration dates | 2021-11, 2022-01, 2022-02 |
Product
Sumatriptan Succinate Tablets, 100 mg packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ
Reason for recall
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0660-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.